Loading...
EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis
Recurrence and metastasis remain the major cause of cancer mortality. Even for early-stage lung cancer, adjuvant chemotherapy yields merely slight increase to patient survival. EF-hand domain-containing protein D2 (EFHD2) has recently been implicated in recurrence of patients with stage I lung adeno...
Na minha lista:
| Udgivet i: | Redox Biol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243194/ https://ncbi.nlm.nih.gov/pubmed/32446175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2020.101571 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|